.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In August 2026, Glacial Gold concentrated 70.11% of sales in Capsules, up 14.97% year over year but down 8.02% month over month, while Vapor Pens held 15.05% share with a 30.22% YoY decline and a 10.87% MoM drop. Oil accounted for 14.53% share with an 8.71% YoY contraction but a 6.88% MoM rise, and Pre-Roll fell to 0.31% share with an 85.76% YoY and 53.34% MoM decline. Despite brand-wide sales down 64.93% YoY and average price up 1.20% YoY to $36.91, Capsules pricing at $39.80 versus Oil at $36.70 signals margin concentration in the lead category. The pattern implies a reliance on a single category to offset multi-quarter contraction, with rank position 1 in Capsules in British Columbia anchoring mix stability even as non-core categories retreat.
With Capsules at rank 1 in British Columbia and commanding 70.11% share, the 8.02% MoM pullback alongside a 6.88% MoM lift in Oil indicates near-term substitution risk within the portfolio, while the 10.87% MoM decline in Vapor Pens reduces cross-category reach. The 30.22% YoY drop in Vapor Pens and the 85.76% YoY collapse in Pre-Roll compress trial vectors, leaving Capsules’ 14.97% YoY gain to carry positioning in efficacy-led formats. The implication is a defensive posture: maintain leadership and pricing power in Capsules while Oil absorbs incremental demand shifts, but portfolio breadth narrows as Pen and Pre-Roll declines outpace Capsules’ gains.
Competitive Landscape
Glacial Gold holds rank #1 in BC Capsules in August 2026, unchanged YoY from rank #1, and it also stayed #1 over the last three months, indicating a flat rank trajectory at the category’s peak; meanwhile, Emprise Canada sits at #2 with a -32.5% YoY sales change and Indiva is #3 with a -47.7% YoY sales change, while Nutra moved up from #6 YoY to #5 with +34.9% YoY sales and Simply Bare holds #4 with +6.0% YoY sales; the combination of Glacial Gold’s steady #1 and competitors either declining in sales or advancing from lower ranks implies the brand’s leadership is currently defended more by peers’ contraction than by incremental share gains, signaling vigilance is needed against upward momentum from faster-growing challengers.
Notable Products
CBD/THC 1:1 Balanced Softgel 50-Pack (500mg CBD, 500mg THC) posted the sharpest movement in August 2026 with a -15.1% MoM decline while holding rank 2, contrasted with THC Softgels 100-Pack (1000mg) at rank 1 slipping a smaller -8.7% MoM; the oil portfolio diverged as CBD/THC 30:30 Max Balanced Drops (35ml) rose +12.0% MoM at rank 6 while Max Thc 30 Drops (35ml) fell -9.3% MoM at rank 7. Five of the top ten are Capsules, and within that cluster THC 10 Softgels 50-Pack (500mg) dropped -19.0% MoM at rank 5 as the CBD 50 Softgels 50-Pack (2500mg CBD) in rank 9 eked out +1.9% MoM, while the new Anytime - CBD/THC 1:1 Honey Dewcumber Distillate Disposable (1g) entered at rank 8 with $53,925 and no prior baseline. The pattern implies Capsules remain the volume anchor but are entering price- or inventory-sensitive contraction, with Oils stabilizing mix and a single new Vapor Pen testing incremental reach.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
